Craven House Capital Regulatory News (CRV)

13 January 2016

 Craven House Capital plc ("Craven House" or the "Company")

Notice of General Meeting

Craven House Capital (AIM:CRV) has today issued a circular (the "Circular") to shareholders in the Company ("Shareholders") containing a notice of a general meeting (the " General Meeting" or "GM").

The resolutions proposed at the GM are to increase the Company's authorised share capital and the authority to allot shares on a non-premptive basis.

The Company is currently in discussions with a number of prospective investors from emerging markets with regard to making a significant capital investment in the Company via a subscription for new ordinary shares. The terms of any capital investment are yet to be finalised and will be subject to the clearance of all applicable regulatory approvals both in the UK and overseas jurisdictions. It is the current intention of the board to effect the subscription through a placing of new Ordinary shares to the interested investors.

In order to effect this placing, the Company is seeking to enlarge its authorised share capital, to grant authority to the Directors to allot shares for cash and to disapply statutory pre-emption rights.

There can be no guarantee that any capital investment in the Company will be made.

A copy of the Circular can be found on the Company's website: www.Cravenhousecapital.com.

~ Ends ~

For further information please contact:

About Craven House Capital

Craven House Capital (AIM:CRV) is an investment company seeking deep value opportunities across the globe. It seeks to create long-term shareholder value on a per share basis by deploying patient capital. Craven House seeks to acquire real assets and operating companies that capable of generating steady cash flows.